endure
发表于 2025-3-25 05:38:06
http://reply.papertrans.cn/39/3881/388096/388096_21.png
Reservation
发表于 2025-3-25 11:10:12
Are Edge Weights in Summary Graphs Useful? - A Comparative Studyity for the fourth edition, the fifth edition, and now the sixth edition was not taken lightly. The task has been a formidable one. I have always had great respect professionally for Dr. Cynthia Westcott. That respect has grown considerably with the completion of the three editions. I now fully real
fastness
发表于 2025-3-25 12:27:51
“It Seems Like a Lie”: The Everyday Politics of World-Making in Contemporary Peruplores the possibility of opening up politics and the public to animistic practices like the . and .. These practices enact the possibility of fertility, protection, and even the productivity of tractors and other modern machinery. Stensrud argues that the . and other similar practices are not symbo
JEER
发表于 2025-3-25 18:11:53
http://reply.papertrans.cn/39/3881/388096/388096_24.png
挣扎
发表于 2025-3-25 22:13:25
http://reply.papertrans.cn/39/3881/388096/388096_25.png
accrete
发表于 2025-3-26 02:46:52
Contextual Coding in Memory: Studies of Remembered Durationmetatheoretical approaches overlaps somewhat, one of them is clearly older. The older metatheory has roots in the behavioristic and neobehavioristic psychology of the earlier part of this century, but it extends it; branches into some recent information processing psychology. I refer to this as a .
CRUDE
发表于 2025-3-26 07:38:12
1860-4862 r implementation, including management, evaluation, risk man.This book comprehensively covers various aspects of research and development (R&D). Intended for a classroom or professional setting, the book provides valuable insights into the significance of R&D for organizations, its role in enhancing
招待
发表于 2025-3-26 09:45:19
http://reply.papertrans.cn/39/3881/388096/388096_28.png
舔食
发表于 2025-3-26 12:50:08
Dermatologic Toxicities to Melanoma Targeted Therapiesma-targeted therapy using BRAF inhibitors (e.g., vemurafenib) and MEK inhibitors (e.g., trametinib) and immune checkpoint antibodies with anti-CTLA-4 (e.g., ipilimumab) and anti-PD-1 (e.g., nivolumab).
exhibit
发表于 2025-3-26 20:12:08
1866-3370 ety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.978-3-031-12186-9978-3-031-12184-5Series ISSN 1866-3370 Series E-ISSN 1866-3389